Pregnancy loss affects nearly one in four pregnancies, with most miscarriages occurring in the first trimester and roughly half linked to genetic or chromosomal abnormalities. When these losses happen ...
Study of 99 pediatric patients found clinically significant CNVs in 30% of cases, supporting CMA as a first-tier test for developmental delay and ID. Clinically significant CNVs were identified in 30% ...
The MarketWatch News Department was not involved in the creation of this content. Market Growth Fueled by Advancements in Genetic Testing and Rising Demand for Personalized Medicine REDDING, Calif., ...
Of the final sample, 31% of patients received at least one genetic test overall, but only 11% received concordant testing and at least one other test. Examining rates of genetic testing for autism ...
Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...
Applied Biosystems™ CytoScan™ Dx and Chromosome Analysis Suite (ChAS) Dx software provide complete solution to support cytogenetic testing CARLSBAD, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback